Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FD.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FD.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FD.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FD.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.8ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.8ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used